Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,071 public trials 3,731 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

NCT05780814

Conditions
Body Weight, Body Weight Changes, Breast Cancer, +17 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Sidney Kimmel Comprehensive Cancer Center, the Avon Foundation Breast Center at Johns Hopkins Baltimore, Maryland, United States
  • Johns Hopkins Bayview Baltimore, Maryland, United States
  • Johns Hopkins Kimmel Cancer Center at Greenspring Station Lutherville, Maryland, United States
View Trial Details
Recruiting

GammaPod Dose Escalation Radiation for Early Stage Breast Cancer

NCT04234386

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • UMMC Baltimore, Maryland, United States
  • Upper Chesapeake Health Bel Air, Maryland, United States
  • Central Maryland Oncology Center Columbia, Maryland, United States
  • Baltimore Washington Medical Center Glen Burnie, Maryland, United States
View Trial Details
Recruiting

Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer

NCT06446882

Conditions
Breast Diseases, Breast Neoplasms, Early-Stage Breast Cancer, +5 more
Locations
  • MUG-Univ.-Klinik für Frauenheilkunde und Geburtshilfe, Klinische Abteilung für Gynäkologie Graz, Austria
  • Lkh Hochsteiermark-Leoben Leoben, Austria
  • Ordensklinikum Linz, Barmherzige Schwestern, Bhs Linz, Austria
  • Uniklinikum Salzburg Salzburg, Austria
View all 29 locations
View Trial Details
Recruiting

Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

NCT05378204

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Francois Baclesse Caen, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges Francois Leclerc Dijon, France
View all 25 locations
View Trial Details
Recruiting

FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

NCT06877949

Conditions
Breast Diseases, Breast Neoplasms, Disease Attributes, +9 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Esbjerg and Grindsted Hospital Esbjerg, Denmark
View Trial Details

Related conditions